JP2018509479A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018509479A5 JP2018509479A5 JP2018502052A JP2018502052A JP2018509479A5 JP 2018509479 A5 JP2018509479 A5 JP 2018509479A5 JP 2018502052 A JP2018502052 A JP 2018502052A JP 2018502052 A JP2018502052 A JP 2018502052A JP 2018509479 A5 JP2018509479 A5 JP 2018509479A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- potato polysaccharide
- potato
- polysaccharide preparation
- polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000004676 glycans Chemical class 0.000 claims description 38
- 229920001282 polysaccharide Polymers 0.000 claims description 38
- 239000005017 polysaccharide Substances 0.000 claims description 38
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 34
- 244000061456 Solanum tuberosum Species 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 25
- 241000124008 Mammalia Species 0.000 claims description 14
- 102000013455 Amyloid beta-Peptides Human genes 0.000 claims description 7
- 108010090849 Amyloid beta-Peptides Proteins 0.000 claims description 7
- 230000037396 body weight Effects 0.000 claims description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- 208000024827 Alzheimer disease Diseases 0.000 claims description 2
- 210000000577 adipose tissue Anatomy 0.000 claims description 2
- 229940087168 alpha tocopherol Drugs 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 235000019136 lipoic acid Nutrition 0.000 claims description 2
- 235000012015 potatoes Nutrition 0.000 claims description 2
- 229960002663 thioctic acid Drugs 0.000 claims description 2
- 229960000984 tocofersolan Drugs 0.000 claims description 2
- 235000004835 α-tocopherol Nutrition 0.000 claims description 2
- 239000002076 α-tocopherol Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 17
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562139178P | 2015-03-27 | 2015-03-27 | |
| US62/139,178 | 2015-03-27 | ||
| PCT/US2016/024295 WO2016160594A1 (en) | 2015-03-27 | 2016-03-25 | Methods and materials for reducing amyloid beta levels within a mammal |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018509479A JP2018509479A (ja) | 2018-04-05 |
| JP2018509479A5 true JP2018509479A5 (enExample) | 2019-05-09 |
Family
ID=57006339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018502052A Pending JP2018509479A (ja) | 2015-03-27 | 2016-03-25 | 哺乳動物内のアミロイドβレベルを減少させるための方法および物質 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10639322B2 (enExample) |
| EP (1) | EP3273972A4 (enExample) |
| JP (1) | JP2018509479A (enExample) |
| AU (1) | AU2016243516A1 (enExample) |
| CA (1) | CA2981138A1 (enExample) |
| WO (1) | WO2016160594A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2924597A1 (en) | 2013-09-19 | 2015-03-26 | The Research Foundation For The State University Of New York | Methods and materials for treating diabetes or liver steatosis |
| WO2016160594A1 (en) | 2015-03-27 | 2016-10-06 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2134714A (en) | 1936-11-25 | 1938-11-01 | Jacob A Glassman | Saccharine-aspirin tablet |
| US3622677A (en) | 1969-07-07 | 1971-11-23 | Staley Mfg Co A E | Compressed tablets containing compacted starch as binder-disintegrant ingredient |
| WO1998033937A2 (de) | 1997-02-03 | 1998-08-06 | Max-Delbrück-Centrum für Molekulare Medizin | GENOMISCHE SEQUENZ DES HUMANEN ν-OPIOID-REZEPTOR GENES SOWIE SEINER VARIANTEN, POLYMORPHISMEN UND MUTATIONEN |
| JP2001511153A (ja) | 1997-02-04 | 2001-08-07 | ブイ． コスバブ，ジョン | 血管変性性疾患の予防および処置のための組成物および方法 |
| US20050085498A1 (en) | 1998-05-28 | 2005-04-21 | Byrd Edward A. | Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate |
| US6376549B1 (en) | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
| US20030159178A1 (en) | 2000-02-10 | 2003-08-21 | Peter Ulvskov | Method for remodelling cell wall polysaccharide structures in plants |
| US7590493B2 (en) | 2000-07-31 | 2009-09-15 | Ocimum Biosolutions, Inc. | Methods for determining hepatotoxins |
| DE10045059A1 (de) | 2000-09-12 | 2002-03-21 | Basf Ag | Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen |
| WO2002032905A1 (en) | 2000-10-20 | 2002-04-25 | Ajinomoto Co.,Inc. | Medicinal compositions, dose and method for treating malaria |
| US7098239B2 (en) | 2001-06-20 | 2006-08-29 | Merck & Co., Inc | Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| GB0117767D0 (en) | 2001-07-20 | 2001-09-12 | Unilever Plc | Polymers and their synthesis |
| US20050031651A1 (en) * | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20050180962A1 (en) | 2003-01-30 | 2005-08-18 | Eyal Raz | Inactivated probiotic bacteria and methods of use thereof |
| US20050214413A1 (en) | 2003-08-26 | 2005-09-29 | Mannatech, Inc. | Methods and compositions for modified release of nutritional supplements |
| US20050053664A1 (en) | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| GB0421639D0 (en) * | 2004-09-29 | 2004-10-27 | Proteome Sciences Plc | Methods and compositions relating to alzheimer's disease |
| JP3998695B2 (ja) | 2005-04-22 | 2007-10-31 | 株式会社シクロケム | αリポ酸水溶液及びその製造方法 |
| WO2006114019A1 (en) * | 2005-04-26 | 2006-11-02 | Versitech Limited | Polysaccharide extract from lycium barbarum as neuroprotective agent against beta-amyloid peptide neurotoxicity |
| US7560536B2 (en) | 2005-05-18 | 2009-07-14 | Virginia Tech Intellectual Properties, Inc. | Morning glory-derived anticancer agents, and novel ipomoeassin compounds |
| JP4863204B2 (ja) | 2005-06-15 | 2012-01-25 | 独立行政法人産業技術総合研究所 | 腎症関連疾患の診断方法及び診断キット |
| JP5247012B2 (ja) | 2006-07-25 | 2013-07-24 | 雪印メグミルク株式会社 | 脂肪肝抑制剤 |
| NZ577427A (en) | 2007-01-18 | 2011-09-30 | Novozymes As | Method for producing potato products using debranching enzymes pullulanase and isoamylase |
| JP2009007309A (ja) | 2007-06-29 | 2009-01-15 | Riken Vitamin Co Ltd | α−リポ酸含有多芯型マイクロカプセル |
| KR101121543B1 (ko) * | 2007-07-04 | 2012-03-06 | 학교법인 선목학원 | 벼과식물로부터 수득되는 전분 또는 식이섬유를 포함하는허혈성 질환 및 퇴행성 뇌질환의 예방 및 치료를 위한조성물 |
| US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| JP2013506427A (ja) | 2009-10-02 | 2013-02-28 | ユニバーシティ オブ アイダホ | 強化した難消化性デンプン含有量および抑制された血糖上昇応答を有するジャガイモ製品ならびにその方法 |
| KR101093413B1 (ko) | 2009-10-05 | 2011-12-14 | 고려대학교 산학협력단 | 뇌 신경 세포 보호 활성을 갖는 고구마 추출물 및 그의 용도 |
| CN102762597A (zh) | 2009-12-11 | 2012-10-31 | 联合利华公众股份有限公司 | 适合调节免疫应答的多糖 |
| WO2012016050A2 (en) | 2010-07-28 | 2012-02-02 | The General Hospital Corporation | Chemoradiotherapy for kras-mutant colorectal cancer |
| JP2012149004A (ja) | 2011-01-18 | 2012-08-09 | Theravalues Corp | 核内受容体の賦活剤 |
| JP6185473B2 (ja) | 2011-09-16 | 2017-08-23 | ガレクティン・セラピューティクス・インコーポレイテッドＧａｌｅｃｔｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | 非アルコール性脂肪性肝炎および非アルコール性脂肪肝疾患を処置するためのガラクト−ラムノガラクツロネート組成物 |
| WO2013148282A1 (en) | 2012-03-28 | 2013-10-03 | The Research Foundation Of State University Of New York | Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation |
| US9814255B2 (en) | 2012-05-20 | 2017-11-14 | Darco Natural Products Inc. | Method for producing purple sweet potato juice and dried powder |
| US9180212B2 (en) | 2012-05-22 | 2015-11-10 | The Regents Of The University Of California | β-amyloid plaque imaging agents |
| EP2902499B1 (en) | 2012-09-28 | 2018-09-12 | BNA Inc. | Bna clamp method |
| GB201223365D0 (en) | 2012-12-24 | 2013-02-06 | Provexis Natural Products Ltd | Compositions |
| CN103110657A (zh) | 2013-01-31 | 2013-05-22 | 黄仁彬 | 玉郎伞多糖在制备药物中的应用 |
| MX359626B (es) | 2013-03-15 | 2018-10-01 | Alltech Inc | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o afecciones asociadas con disfunción mitocondrial. |
| EP3008212A4 (en) | 2013-06-10 | 2017-05-24 | Millennium Pharmaceuticals, Inc. | Methods of treatment of cancer |
| CA2924597A1 (en) | 2013-09-19 | 2015-03-26 | The Research Foundation For The State University Of New York | Methods and materials for treating diabetes or liver steatosis |
| KR102448455B1 (ko) | 2014-03-14 | 2022-09-28 | 올텍 법인회사 | 셀레노유기 화합물의 조성물 및 이의 사용 방법 |
| WO2016160590A1 (en) | 2015-03-27 | 2016-10-06 | The Research Foundation For The State University Of New York | Methods and materials for treating cancer |
| WO2016160594A1 (en) | 2015-03-27 | 2016-10-06 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
| WO2017160678A1 (en) | 2016-03-14 | 2017-09-21 | Mitogenetics, Llc | Materials and methods for treating hypoxic conditions |
-
2016
- 2016-03-25 WO PCT/US2016/024295 patent/WO2016160594A1/en not_active Ceased
- 2016-03-25 US US15/562,149 patent/US10639322B2/en not_active Expired - Fee Related
- 2016-03-25 EP EP16773856.6A patent/EP3273972A4/en not_active Withdrawn
- 2016-03-25 CA CA2981138A patent/CA2981138A1/en not_active Abandoned
- 2016-03-25 AU AU2016243516A patent/AU2016243516A1/en not_active Abandoned
- 2016-03-25 JP JP2018502052A patent/JP2018509479A/ja active Pending
-
2020
- 2020-05-04 US US16/866,366 patent/US11253538B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012021005A5 (enExample) | ||
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| JP2013542195A5 (enExample) | ||
| BR112015010203A8 (pt) | composição para a prevenção ou tratamento de diabetes, complicações diabéticas ou diabesidade, uso de um conjugado análogo da oxintomodulina, e, método para a preparação de um conjugado análogo da oxintomodulina | |
| BR112013025517A2 (pt) | uso de 2,3-diidroimidazo[1,2-c]quinazolinas substituídas | |
| JP2018527305A5 (enExample) | ||
| JP2017522288A5 (enExample) | ||
| JP2020504129A (ja) | 非アルコール性脂肪性肝炎（ｎａｓｈ）および肝線維症のための併用療法 | |
| JP2018509479A5 (enExample) | ||
| JP2014513121A5 (enExample) | ||
| JP2016535762A5 (enExample) | ||
| WO2019100843A1 (zh) | 一种浒苔多糖复合降血脂保健品及其制备方法 | |
| US20200138776A1 (en) | Composition for use in the treatment of endometriosis and symptoms associated with endometriosis | |
| HK1209041A1 (en) | A method of weight reduction | |
| CN106619618B (zh) | 一种缬沙坦药物组合物及其制备方法 | |
| Wang et al. | Glucan phosphate inhibits HMGB-1 release from rat myocardial H9C2 cells in sepsis via TLR4/NF-кB signal pathway | |
| JP2011032256A (ja) | 薬用ニンジンを始めとしたサポニン含有生薬服用時に生じるメンゲン反応の防止及び生薬の吸収性を増大させる製法（生薬の有効成分を鶏卵タンパクに吸収させる方法）による医薬組成物及び健康食品 | |
| Aksu | Alveolar haemorrhage and interstitial lung disease: case report | |
| JP2016188260A5 (enExample) | ||
| Lee et al. | Effects of Gami-Handayeolso-Tang on Body Fat Reduction in High Fat Diet-Fed Obese Mice | |
| Cisneros Serrano | Omalizumab/prednisone | |
| Vallakati | Digoxin/dronedarone interaction | |
| KR101870012B1 (ko) | Tis21의 발현조절제를 유효성분으로 포함하는 비알콜성 지방간 예방 또는 치료용 조성물 | |
| Koike | Interstitial pneumonia: 8 case reports | |
| TWI507196B (zh) | 赤靈酸ｓ用於製造癌症治療藥物的新穎用途 |